Suraksha Diagnostic IPO Details

• Issue Size: ₹846.25 crores (entirely an offer for sale of 1.92 crore shares).
• Price Band: ₹420 to ₹441 per equity share.
• Subscription Dates: Opens on November 29, 2024, and closes on December 3, 2024.
• Minimum Lot Size: 34 shares, with a minimum investment of ₹14,994 for retail investors.
• sNII (Small NII) Minimum Investment: ₹209,916 (14 lots).
• bNII (Big NII) Minimum Investment: ₹1,004,598 (67 lots).
• Listing Details: Shares to list on BSE and NSE, with a tentative listing date of December 6, 2024.

Lead Managers and Registrar

• Book Running Lead Managers (BRLMs):

  • ICICI Securities Limited
  • Nuvama Wealth Management Limited
  • SBI Capital Markets Limited

• Registrar:

  • KFin Technologies Limited

About Suraksha Diagnostic Limited

Incorporated in 2005, Suraksha Diagnostic Limited is a healthcare provider offering comprehensive pathology, radiology testing, and medical consultancy services.

Key operational highlights include:

• Extensive Network:

  • Central reference lab with 8 satellite labs and 215 customer touchpoints.
  • 49 diagnostic centers and 166 sample collection centers.

• Integrated Services:

  • Pathology, radiology, and medical consultancy under one roof.
  • Offers customized testing packages for disease prediction and early detection.

• Technological Innovation:

  • Uses AI-powered diagnostic tools and digital pathology.
  • Fully integrated systems like LIMS, RIS, PACS, and ERP for efficient operations.

Competitive Strengths

1. Regional Leadership: Dominates the fragmented diagnostic market in eastern and northeastern India.
2. Integrated Services: Single-source provider for pathology, radiology, and medical consultancy.
3. Technological Infrastructure: Advanced clinical and digital systems improve service quality and reduce turnaround time.
4. Customer Retention: High-quality standards ensure strong customer loyalty and repeat business.

Key Dates to Remember

Investor Insights

• Offer Structure: The IPO is fully an Offer for Sale, allowing existing shareholders to divest stakes.
• Retail Investors: Minimum lot size investment is ₹14,994 for 34 shares.
• Large Investors: Tailored opportunities for small and big non-institutional investors with defined minimum investments.

Conclusion

Suraksha Diagnostic IPO offers investors an opportunity to participate in a leading healthcare diagnostics chain with a robust network and advanced technological framework. With its competitive strengths and significant market position in India’s east and northeast, it may attract both retail and institutional investors.

Investors should evaluate the IPO pricing, market conditions, and company fundamentals before subscribing.